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Emerging Infections in Asia com-
prises a selection of scientific and his-
torical review chapters on a variety of 
infectious diseases and includes con-
tributors from diverse locations rang-
ing from Saudi Arabia to Australia. The 
book arose from the editors’ experience 
with the emerging infections described 
and  from  their  professional  associa-
tions with the other contributors. The 
book is divided into 3 disease-specific 
sections that focus on avian influenza, 
severe  acute  respiratory  syndrome 
(SARS), and HIV/AIDS, respectively; 
a fourth section contains short reviews 
of other infections. Because of the rel-
atively small size of the book for such 
a broad topic (250 pages), each section 
covers only a few specific topics for 
each selected disease.
The  book  contains  some  well-
written  reviews  and  valuable  narra-
tive  histories  that  are  important  to 
document (e.g., the 2003 SARS out-
breaks  in  Singapore  and  Taiwan). 
The  chapters  on  SARS  in  animals 
and  emerging  paramyxoviruses  are 
particularly interesting, and the book 
includes topics (e.g., Escherichia coli 
and  Staphylococcus  aureus)  that  are 
often  overshadowed  by  more  glam-
orous emerging infections. However, 
it is disappointing in that the first 2 
chapters contradict one another on the 
occurrence of person-to-person trans-
mission of influenza virus A (H5N1), 
and  the  chapter  on  SARS  in  China 
could have been improved with more 
rigorous editing. Most chapters appear 
to have been written around 2006, and 
although they provide good snapshots 
of the state of knowledge at that time, 
readers will need to look elsewhere for 
more recent developments. 
Emerging Infections in Asia also 
misses an opportunity to pull together 
the diverse topics and experiences dis-
cussed to provide new insights into the 
emergence of infectious diseases and 
into responses to the constantly shift-
ing challenge of emerging infections. 
Recognizing this drawback, the editors 
say in their preface, “We hope that our 
book can help readers make their own 
conclusions and ask more questions.” 
Approached in this context, the book 
provides an account of the diversity 
and challenges of emerging infectious 
diseases in Asia and some informative 
historical reviews that will be of inter-
est to students exploring this fascinat-
ing topic.
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War and Disease is a fascinating 
historical account of the discovery of 
drugs  effective  against  malaria,  one 
of the great scourges of humankind. 
The author, Leo B. Slater, makes good 
use of his expertise as a historian of 
biomedical  science  and  technology. 
He provides a meticulous reconstruc-
tion of the manner in which the scien-
tific community, in the midst of World 
War  II,  established  an  antimalarial 
program,  which  was  to  biomedical 
research what the Manhattan Project 
was to the physical sciences. At a time 
when  industrialized  nations  are  in-
volved in the effort to find solutions to 
the ongoing global health catastrophe 
that malaria is today, this volume is a 
timely and valuable contribution.
Malaria’s effects have long been 
at  the  center  of  colonial  expansion 
and  war.  The  disease  became  a  fo-
cus of research in the late nineteenth 
century. France and Great Britain had 
expanded their colonies into areas of 
the world where malaria was the most 
severe and debilitating of the parasitic 
tropical diseases—a factor that limited 
the colonial governments’ exploitation 
of natural resources. Malariologic re-
search thrived in these countries and 
in  Italy,  where  the  disease  was  not 
a  colonial  problem  but  an  endemic 
scourge and overwhelming obstacle to 
development, just as it is in many de-
veloping countries today. From 1880 
through 1898 research carried out by 
such prominent scientists as Charles-
Louis-Alphonse  Laveran,  Ronald 
Ross, Angelo  Celli,  Ettore  Marchia-
fava,  and  Giovanni  Battista  Grassi 
led  to  the  discovery  of  the  malaria 
transmission  cycle.  The  neurologist, 
Camillo Golgi, who shared the 1906 
Nobel Prize for his work on the struc-
ture  of  the  nervous  system,  studied 
the reproductive cycle of the parasite 
(Plasmodium  spp.)  and  elucidated 
the synchronicity between the symp-
toms of recurrent chills and fever and 
the rupture and release of merozoites 
into the blood. These findings offered 
an  explanation  for  the  effectiveness 
of treatment with quinine, which had 
been  used  empirically  as  a  generic 
febrifuge since the 17th century. The 
alkaloid  remained  the  only  effective 
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option  for  treating  malaria  until  the 
1930s.
During World War II the disease 
reached epidemic proportions among 
American troops fighting the Japanese 
in the South Pacific. Quinine was the 
main line of defense, but the supply of 
quinine was cut off by Japanese mili-
tary  conquest.  The  development  of 
new antimalarial drugs became a ma-
jor subject of research. Three chapters 
of the book—Preparing for War, Prep-
aration  and  Coordination,  Trust  and 
Transition—focus on the comprehen-
sive research program, which integrat-
ed exceptional technical and scientific 
expertise into a massive organizational 
and cooperative effort. Funded by the 
United States Office of Scientific Re-
search and Development, this program 
screened ≈14,000 compounds for anti-
malarial efficacy. Clinically approved 
Atabrine (quinacrine) became the drug 
of choice in 1943, and, shortly after 
the  war,  chloroquine  was  identified, 
which has had an enduring influence 
on  antimalarial  chemotherapy.  The 
wartime effort, Slater argues, was es-
sential to the development of the US 
National Institutes of Health. Making 
a critical point, however, he suggests 
that although the wartime antimalarial 
program is an excellent model for fu-
ture  large-scale  biomedical  research 
projects, it is “a potential example of 
how  not  to  pursue  public  health  re-
search for impoverished civilians” (p. 
2). The transfer of research results into 
health benefits for the most vulnerable 
persons in malarial lands was not on 
the  agenda.  The  widespread  useful-
ness of a drug such as chloroquine was 
only a side effect.
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